Gapping up
In reaction to earnings/guidance:
- AZO +2.7%, J +0.9% (reaffirms Q4 EPS and adjusted EBITDA guidance)
Other news:
- PRPL +32.6% (confirms it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share)
- KNBE +24.9% (received a non-binding proposal from Vista Equity Partners Management to acquire all of the outstanding shares at $24/share)
- BLUE +6.5% (receives FDA accelerated approval for SKYSONA Gene Therapy)
- WIX +5.3% (Starboard Value building an approximately 9% stake in the company, according to Reuters)
- AGIO +5% (appoints Cecilia Jones as CFO)
- ALLK +3.7% (priced an underwritten offering of 29,882,000 shares of its common stock at an offering price of $5.02/share)
- TBPH +3.2% (initiates $250 million capital return program)
- EAF +1.3% (Mexico govt has issued a temporary suspension notice for its Monterrey facility)
- EWTX +1% (closing of its upsized offering of 13,372,093 shares at a price to the public of $10.32 per share)
Analyst comments:
- ARRY +3.4% (upgraded to Overweight from Neutral at Piper Sandler)
- LEN +0.9% (upgraded to Overweight from Underweight at KeyBanc Capital Markets)
- MTH +0.9% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- TOL +0.9% (upgraded to Sector Weight from Underweight at KeyBanc Capital Markets)
- BLD +0.9% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)